Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody–Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer
Year: 2022
Type: article
Source: Molecular Cancer Therapeutics
Authors: Stephen J. Gregson, Kathryn Pugh, Neki Patel, Shameen Afif-Rider, Balakumar Vijayakrishnan, Kathleen Santos, Jitka Riedl, Ian Hutchinson, Gyoung-Dong Kang, K. Phin Chooi, Rhiannon Beard, Lauren Adams, Conor S. Barry, Kathryn Ball, Luke A. Masterson, Mary McFarlane, John A. Hartley, Philip W. Howard
Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States)
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4284890639